Phio Pharmaceuticals Other Long Term Assets (Quarterly) Analysis

Phio Pharmaceuticals Corp. (PHIO)

1.035 -0.04 (-4.17%) USD | NASDAQ | Jan 21, 16:00

1.04 0.00 (0.00%) After-Hours: 17:55

View Other Long Term Assets (Quarterly) for PHIO.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

Tharimmune, Inc.	--
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade
Theriva Biologics, Inc.	Upgrade
Oragenics, Inc.	--